HIGHLIGHTS
- What: All the studies included within this review referenced clinical data from RCTs that were conducted amongst an adult population of ages 18+ who met the study`s inclusion criteria.
- Who: Zhihao Wang from the University College London, London, United Kingdom have published the research work: The Effectiveness and Cost-Effectiveness of Digital Therapeutics for Prevention and Management of Hypertension, in the Journal: (JOURNAL) of 25/Nov/2024
- How: The studies evaluated the primary outcome based on change to 24-h SBP levels from baseline (n=2) or adherence to medication (n=1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.